Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-01-16
2007-01-16
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S025000, C514S04400A, C514S050000, C536S027100, C536S028100, C536S028200
Reexamination Certificate
active
10602135
ABSTRACT:
A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
REFERENCES:
patent: 3480613 (1969-11-01), Walton et al.
patent: 5977061 (1999-11-01), De Clercq
patent: 6063628 (2000-05-01), Loeb et al.
patent: 6340690 (2002-01-01), Bachand et al.
patent: 6348587 (2002-02-01), Schinazi et al.
patent: 6395716 (2002-05-01), Gosselin et al.
patent: 6444652 (2002-09-01), Gosselin et al.
patent: 6455508 (2002-09-01), Ramasamy et al.
patent: 6495677 (2002-12-01), Ramasamy et al.
patent: 6566344 (2003-05-01), Gosselin et al.
patent: 6566365 (2003-05-01), Storer
patent: 6569837 (2003-05-01), Gosselin et al.
patent: 6573248 (2003-06-01), Ramasamy et al.
patent: 6605614 (2003-08-01), Bachand et al.
patent: 6660721 (2003-12-01), Devos et al.
patent: 6748161 (2004-06-01), Ko et al.
patent: 6777395 (2004-08-01), Bhat et al.
patent: 6784166 (2004-08-01), Devos et al.
patent: 6787526 (2004-09-01), Bryant et al.
patent: 6812219 (2004-11-01), LaColla et al.
patent: 6815542 (2004-11-01), Hong et al.
patent: 6831069 (2004-12-01), Tam et al.
patent: 6908924 (2005-06-01), Watanabe et al.
patent: 6911424 (2005-06-01), Schinazi et al.
patent: 6914054 (2005-07-01), LaColla et al.
patent: 2002/0019363 (2002-02-01), Ismaili et al.
patent: 2002/0055483 (2002-05-01), Watanabe et al.
patent: 2002/0099072 (2002-07-01), Bachand et al.
patent: 2002/0147160 (2002-10-01), Bhat et al.
patent: 2002/0156030 (2002-10-01), Ramasamy et al.
patent: 2003/0008841 (2003-01-01), Devos et al.
patent: 2003/0028013 (2003-02-01), Wang et al.
patent: 2003/0050229 (2003-03-01), Sommadossi et al.
patent: 2003/0060400 (2003-03-01), LaColla et al.
patent: 2003/0083307 (2003-05-01), Devos et al.
patent: 2003/0087873 (2003-05-01), Stuyver et al.
patent: 2003/0220290 (2003-11-01), Gosselin et al.
patent: 2003/0225028 (2003-12-01), Gosselin et al.
patent: 2003/0225037 (2003-12-01), Storer
patent: 2003/0236216 (2003-12-01), Devos et al.
patent: 2004/0002476 (2004-01-01), Stuyver et al.
patent: 2004/0002596 (2004-01-01), Hong et al.
patent: 2004/0023921 (2004-02-01), Hong et al.
patent: 2004/0059104 (2004-03-01), Cook et al.
patent: 2004/0063622 (2004-04-01), LaColla et al.
patent: 2004/0063658 (2004-04-01), Roberts et al.
patent: 2004/0067901 (2004-04-01), Bhat et al.
patent: 2004/0072788 (2004-04-01), Bhat et al.
patent: 2004/0097461 (2004-05-01), Sommadossi et al.
patent: 2004/0097462 (2004-05-01), LaColla et al.
patent: 2004/0101535 (2004-05-01), Sommadossi et al.
patent: 2004/0102414 (2004-05-01), Sommadossi et al.
patent: 2004/0110717 (2004-06-01), Carroll et al.
patent: 2004/0110718 (2004-06-01), Devos et al.
patent: 2004/0147464 (2004-07-01), Roberts et al.
patent: 2004/0248844 (2004-12-01), Ismaili et al.
patent: 2005/0009737 (2005-01-01), Clark et al.
patent: 2005/0090463 (2005-04-01), Roberts et al.
patent: 2005/0101550 (2005-05-01), Roberts et al.
patent: 2005/0107312 (2005-05-01), Keicher et al.
patent: 2005/0119200 (2005-06-01), Roberts et al.
patent: 2005/0124532 (2005-06-01), Sommadossi et al.
patent: 2005/0137161 (2005-06-01), Sommadossi et al.
patent: 1521076 (1968-04-01), None
patent: 1581628 (1969-09-01), None
patent: 2662165 (1991-11-01), None
patent: 2662165 (1991-11-01), None
patent: 1163103 (1969-09-01), None
patent: 1209654 (1970-10-01), None
patent: 63-215694 (1988-09-01), None
patent: 63-215694 (1988-09-01), None
patent: 06-228186 (1994-08-01), None
patent: 06-228186 (1994-08-01), None
patent: WO 98/16184 (1998-04-01), None
patent: WO 99/43691 (1999-02-01), None
patent: WO 00/09531 (2000-02-01), None
patent: WO 01/32153 (2001-05-01), None
patent: WO 01/91737 (2001-06-01), None
patent: WO 01/92282 (2001-06-01), None
patent: WO 01/60315 (2001-08-01), None
patent: WO 01/68663 (2001-09-01), None
patent: WO 01/79246 (2001-10-01), None
patent: WO 01/90121 (2001-11-01), None
patent: WO 01/96353 (2001-12-01), None
patent: WO 02/03997 (2002-01-01), None
patent: WO 02/18404 (2002-03-01), None
patent: WO 02/32920 (2002-04-01), None
patent: WO 02/48165 (2002-06-01), None
patent: WO 02/057287 (2002-07-01), None
patent: WO 02/057425 (2002-07-01), None
patent: WO 02/070533 (2002-09-01), None
patent: WO 02/094289 (2002-11-01), None
patent: WO 02/100415 (2002-12-01), None
patent: WO 03/026589 (2003-04-01), None
patent: WO 03/026675 (2003-04-01), None
patent: WO 03/051899 (2003-06-01), None
patent: WO 03/061385 (2003-07-01), None
patent: WO 03/061576 (2003-07-01), None
patent: WO 03/062255 (2003-07-01), None
patent: WO 03/062256 (2003-07-01), None
patent: WO 03/062257 (2003-07-01), None
patent: WO 03/063771 (2003-08-01), None
patent: WO 03/068162 (2003-08-01), None
patent: WO 03/072757 (2003-09-01), None
patent: WO 03/093290 (2003-11-01), None
patent: WO 04/002422 (2004-01-01), None
patent: WO 04/002999 (2004-01-01), None
Altmann et al, “The synthesis of 1′-methyl carbocyclic thymidine and its effect on nucleic acid duplex stability,”Synlett, Thieme Verlag, Stuttgart, De, 10:853-855 (1994).
Baginski, S. G, et al., “Mechanism of action of a pestivirus antiviral compound,”PNAS USA, 97(14):7981-7986 (2000).
Beigelman, L.N., et al, “Epimerization during the acetolysis of 3-O-acetyl-5-O-benzoyl-1,2-O-isopropylidene-3-C-methyl-α,D-ribofuranose. Synthesis of 3′-C-methylnucleosides with the β-D-ribo- and α-D-arabino configurations,”Carbohydrate Research, 181:77-88 (1988).
Beigelman, L.N., et al, “A general method for synthesis of 3'-C-alkylnucleosides,”Nucleic Acids Symp. Ser., 9:115-118 (1981).
Berenguer, M., et al, “Hepatitis B and C viruses: Molecular identification and targeted antiviral therapies,”Proceedings of the Association of American Physicians, 110(2), 98-112 (1998).
Carroll, S.S., et al., “Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs,”The Journal of Biological Chemistry, 278(14):11979-11984 (2003).
Czernecki, S., et al, “Synthesis of various 3′-branched 2′,3′-unsaturated pyrimidine nucleosides as potential anti-HIV agents,”J. Org. Chem., 57:7325-7328 (1992).
De Francesco, R., et al., “Approaching a new era for hepatitis C virus therapy: Inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase,”Antiviral Research, 58:1-16 (2003).
Faivre-Buet, V., et al, “Synthesis of 1′-deoxypsicofuranosyl-deoxynucleosides as potential anti-HIV agents,”Nucleosides&Nucleotides, 11(7):1411-1424 (1992).
Farkas, J., et al., “Nucleic acid components and their analogues. XCIV. Synthesis of 6-amino-9-(1-deoxy-β-D-psicofuranosyl)purine”,Collect. Czech. Chem. Commun. 32:2663-2667 (1967).
Farkas, J., et al., “Nucleic acid components and their analogues. LXXIX. Synthesis of methyl I-deoxy-D-psicofurnanosides substituted at C(1)with halo atoms or a mercapto group,”Collect. Czech. Chem. Commun., 31:1535-1543 (1996).
Fedorov, I.I., et al., “3′-C-Branched 2′-deoxy-5-methyluridines: Synthesis, enzyme inhibition, and antiviral properties,”J. Med. Chem., 35(24):4567-4575 (1992).
Franchetti, P., et al., “2′-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies,”J. Med. Chem., 41(10):1708-1715 (1998).
Grouiller, A., et al., “Novel p-toluenesulfonylation and thionocarbonylation of unprotected thymine nucleosides,”Synlett, 1993, 221-222 (Mar. 1993).
Haraguchi, K., et al., “Preparation and reactions of 2′- and 3′- vinyl bromides of uracil nucleosides: Versatile synthons for anti-HIV agents,”Tetrahedron Letters, 32(28):3391-3394 (1991).
Haraguchi, K., et al., “Stereoselective synthesis of 1′-C-branched uracil nucleosides from uridine,”Nucleosides&Nucleotides, 14(3-5):417-420 (1995).
Harr
LaColla Paulo
Sommadossi Jean-Pierre
Idenix Pharmaceuticals Inc.
King & Spalding LLP
Knowles, Esq. Sherry M.
McIntosh III Traviss C.
Universita Degli Studi Di Cagliari
LandOfFree
Methods and compositions for treating flaviviruses and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating flaviviruses and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating flaviviruses and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3754871